Literature DB >> 9767422

Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis.

H Nagumo1, K Agematsu.   

Abstract

Interleukin-10 (IL-10) is a potent cytokine that regulates immunoglobulin synthesis by B cells. CD27/CD70 interactions by direct cell-to-cell contact are also needed to produce substantial amounts of immunoglobulin. We have investigated the effects of IL-10 and CD27/CD70 interactions on the immunoglobulin synthesis. In the presence of IL-10 stimulation, the production of IgG, IgM and IgA was increased synergistically by the addition of CD27 ligand (CD70)-transfectants in a dose-dependent manner, which was completely blocked by anti-CD70 monoclonal antibody. In contrast, CD70-transfectants additively enhanced the immunoglobulin production in the presence of IL-2, IL-4, or IL-6. The synergistic enhancement of the immunoglobulin production by IL-10 and CD70-transfectants was remarkable in highly purified CD27+ B cells, but there was no immunoglobulin production in CD27- B cells. Furthermore, by the addition of CD70-transfectants, the synthesis of IgG1, IgG2, IgG3 and IgG4 was also enhanced in the presence of IL-10. On the other hand, IL-10 diminished CD27 expression in B cells. B-cell proliferation was augmented by CD70-transfectants with IL-10 or IL-10 plus IL-2. The addition of IL-2 further augmented the immunoglobulin production which was synergistically enhanced by IL-10 and CD27 triggering. Taken together, the co-operative response to IL-10 and CD27/CD70 interactions regulates B-cell immunoglobulin production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767422      PMCID: PMC1364258          DOI: 10.1046/j.1365-2567.1998.00521.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset.

Authors:  D Maurer; G F Fischer; I Fae; O Majdic; K Stuhlmeier; N Von Jeney; W Holter; W Knapp
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

2.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors:  L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

3.  CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling.

Authors:  S Jacquot; T Kobata; S Iwata; C Morimoto; S F Schlossman
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.

Authors:  K Sugita; T Hirose; D M Rothstein; C Donahue; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1992-11-15       Impact factor: 5.422

6.  The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family.

Authors:  D Camerini; G Walz; W A Loenen; J Borst; B Seed
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

7.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Authors:  R G Goodwin; M R Alderson; C A Smith; R J Armitage; T VandenBos; R Jerzy; T W Tough; M A Schoenborn; T Davis-Smith; K Hennen
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.

Authors:  A C Fluckiger; P Garrone; I Durand; J P Galizzi; J Banchereau
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  8 in total

1.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

Review 2.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

3.  Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70.

Authors:  Joanne Shaw; Yui-Hsi Wang; Tomoki Ito; Kazuhiko Arima; Yong-Jun Liu
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

4.  Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis.

Authors:  R Harley; C R Helps; D A Harbour; T J Gruffydd-Jones; M J Day
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

5.  IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction.

Authors:  N Kobayashi; H Nagumo; K Agematsu
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

6.  Double-positive CD21+CD27+ B cells are highly proliferating memory cells and their distribution differs in mucosal and peripheral tissues.

Authors:  Arpita Das; Huanbin Xu; Xiaolei Wang; Canddy L Yau; Ronald S Veazey; Bapi Pahar
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

7.  Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytes.

Authors:  Rayelle Itoua Maïga; Guillaume Bonnaure; Josiane Tremblay Rochette; Sonia Néron
Journal:  J Immunol Res       Date:  2014-12-23       Impact factor: 4.818

Review 8.  B cell dysregulation in primary Sjögren's syndrome: A review.

Authors:  Hazim Mahmoud Ibrahem
Journal:  Jpn Dent Sci Rev       Date:  2019-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.